Graft-Versus-Host Disease (GVHD) Market | Share Analysis and Top Companies Neovii Biotech GmbH, Merck Co., Inc., Astellas Pharma Inc., Soligenix, Inc., Mesoblast Ltd
Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in the
Graft-Versus-Host Disease (GVHD) Market | Share Analysis and Top Companies Neovii Biotech GmbH, Merck Co., Inc., Astellas Pharma Inc., Soligenix, Inc., Mesoblast Ltd
Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in the